In part two of a two-part interview, WInnovations host Dr. Kyle Richards is joined by Dr. Elizabeth Koehne, assistant professor and urologic oncologist at the University of Wisconsin Department of Urology, and Dr. Sam Chang, professor and chief of urologic oncology at Vanderbilt University. The conversation continues with a deeper dive into emerging treatments for non–muscle invasive bladder cancer, with a particular focus on the growing role of biomarkers in guiding care and identifying the right therapy for the right patient. The discussion also further explores evolving strategies for patients with BCG-unresponsive disease, including promising therapeutic options amid the ongoing BCG shortage.

In part one of a two-part interview, WInnovations host Dr. Kyle Richards is joined by Dr. Elizabeth Koehne, assistant professor and urologic oncologist at the University of Wisconsin Department of Urology, and Dr. Sam Chang, professor and chief of urologic oncology at Vanderbilt University, for a forward-looking discussion on emerging treatments for non-muscle invasive bladder cancer. Together, they break down key advances in care – from updates to standard surgical approaches and promising alternatives to navigating the ongoing BCG shortage and exploring new options for patients with BCG-unresponsive disease.

WInnovations host Dr. Kyle Richards welcomes urogynecologist Dr. Frank Lin, Assistant Professor in the University of Wisconsin Department of Urology, and Dr. Jon Pennycuff, Assistant Professor in the Department of Obstetrics and Gynecology at the University of Wisconsin, for an insightful discussion on pelvic organ prolapse. The conversation explores current approaches to diagnosis and treatment, emerging innovations in the field, and a thoughtful examination of the ongoing mesh controversy.